HCPCS Level IIdrugActive
J9271
Inj pembrolizumab
BETOS: O1D
Effective: 2016-01-01
Description
Injection, pembrolizumab, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Keytruda
Manufacturer
Merck Sharp & Dohme LLC
HCPCS Dosage
1 MG
Billing Units
100.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.